DiaMedica Therapeutics Inc

NASDAQ:DMAC   1:09:49 PM EDT
1.44
0.00 (0.00%)
Earnings Announcements

Diamedica Therapeutics Announces Third Quarter 2022 Financial Results

Published: 11/09/2022 21:36 GMT
DiaMedica Therapeutics Inc (DMAC) - Diamedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results.
Diamedica Therapeutics Inc- Cash Runway Into Q4 2024.
Diamedica Therapeutics Inc - Qtrly Loss per Share $0.12.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.